Terms: = Breast cancer AND CREB1, ENSG00000118260, 1385 AND Prognosis
12 results:
1. miR-450a exerts oncosuppressive effects in breast carcinoma by targeting creb1.
Zhang Y; Han XX; Lin XM; Li Z; Zhang JH
Kaohsiung J Med Sci; 2022 Jul; 38(7):643-652. PubMed ID: 35451558
[TBL] [Abstract] [Full Text] [Related]
2. KDELR2 promotes breast cancer proliferation via HDAC3-mediated cell cycle progression.
Wei H; Ma W; Lu X; Liu H; Lin K; Wang Y; Ye Z; Sun L; Huang Z; Pan T; Zhou Z; Cheng EY; Zhang H; Gao P; Zhong X
Cancer Commun (Lond); 2021 Sep; 41(9):904-920. PubMed ID: 34146461
[TBL] [Abstract] [Full Text] [Related]
3. Identification of core genes and clinical roles in pregnancy-associated breast cancer based on integrated analysis of different microarray profile datasets.
Zhang J; Zhou YJ; Yu ZH; Chen AX; Yu Y; Wang X; Cao XC
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31171715
[TBL] [Abstract] [Full Text] [Related]
4. A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients.
Zheng T; Pang Z; Zhao Z
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988073
[TBL] [Abstract] [Full Text] [Related]
5. LINC01857 as an oncogene regulates creb1 activation by interacting with CREBBP in breast cancer.
Xiong Y; Gu Y; Wang F; Li L; Zhu M; Wang N; Mi H; Qiu X
J Cell Physiol; 2019 Aug; 234(8):14031-14039. PubMed ID: 30628071
[TBL] [Abstract] [Full Text] [Related]
6. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
[TBL] [Abstract] [Full Text] [Related]
7. The autophagy GABARAPL1 gene is epigenetically regulated in breast cancer models.
Hervouet E; Claude-Taupin A; Gauthier T; Perez V; Fraichard A; Adami P; Despouy G; Monnien F; Algros MP; Jouvenot M; Delage-Mourroux R; Boyer-Guittaut M
BMC Cancer; 2015 Oct; 15():729. PubMed ID: 26474850
[TBL] [Abstract] [Full Text] [Related]
8. Expression of transcription factor creb1 in human breast cancer and its correlation with prognosis.
Chhabra A; Fernando H; Watkins G; Mansel RE; Jiang WG
Oncol Rep; 2007 Oct; 18(4):953-8. PubMed ID: 17786359
[TBL] [Abstract] [Full Text] [Related]
9. Characterization of a repressor element and a juxtaposed tissue-restricted activator element located on the distal neu gene promoter.
Suen TC; Goss PE
J Biol Chem; 2000 Mar; 275(9):6600-7. PubMed ID: 10692468
[TBL] [Abstract] [Full Text] [Related]
10. E-cadherin and beta-catenin expression in breast medullary carcinomas.
Charpin C; Bonnier P; Garcia S; Andrac L; Crebassa B; Dorel M; Lavaut MN; Allasia C
Int J Oncol; 1999 Aug; 15(2):285-92. PubMed ID: 10402239
[TBL] [Abstract] [Full Text] [Related]
11. Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases.
Reinfuss M; Stelmach A; Mitus J; Rys J; Duda K
J Surg Oncol; 1995 Oct; 60(2):89-94. PubMed ID: 7564387
[TBL] [Abstract] [Full Text] [Related]
12. [Role of radiation therapy in the complex treatment of breast cancer].
Pavlov AS; Datsenko VS
Vopr Onkol; 1978; 24(8):48-54. PubMed ID: 695426
[TBL] [Abstract] [Full Text] [Related]
